板塊異動 | 恆生科技指數午後漲超3%,鴻騰精密漲超12%領漲
uSMART盈立智投12月23日消息,週三港股午後,恆生科技指數漲幅擴大,截至13:20分,恆生科技指數漲3.05%,30只成分股近乎全線飄紅,鴻騰精密漲超12%領漲,京東健康漲超7%,心動公司、小米漲超6%,微盟集團漲超5%,京東集團、金山軟件漲超4%,阿裏健康、美團漲超3%。
跟蹤恆生科技指數的ETF南方恆生科技(3033)亦漲3.01%。
【南方恆生科技(3033)目前支持10倍槓桿日內交易】
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.